Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

337.47
-8.6200-2.49%
Post-market: 337.470.00000.00%19:41 EDT
Volume:496.41K
Turnover:168.12M
Market Cap:23.84B
PE:43.21
High:345.87
Open:344.51
Low:336.13
Close:346.09
52wk High:386.00
52wk Low:223.83
Shares:70.65M
Float Shares:69.93M
Volume Ratio:1.14
T/O Rate:0.71%
Dividend:0.87
Dividend Rate:0.26%
EPS(TTM):7.81
EPS(LYR):6.79
ROE:19.09%
ROA:11.38%
PB:7.97
PE(LYR):49.70

Loading ...

West Pharmaceutical Services (WST) Stock Sees Margin Improvement Narrative Backed By Q2 2026 Results

Simply Wall St.
·
Jul 25

West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers

Dow Jones
·
Jul 25

Movement Alert|West Pharmaceutical Falls 5.41% in Regular Trading, Giving Back Post-Earnings Gains Despite Strong Q2 Beat and Raised Guidance

Market Focus
·
Jul 25

Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating

MT Newswires Live
·
Jul 24

Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating

MT Newswires Live
·
Jul 24

West Pharmaceutical Services Inc : Deutsche Bank Raises Target Price to $420 from $405

THOMSON REUTERS
·
Jul 24

West Pharmaceutical Services (WST) Receives a Buy from Barclays

TIPRANKS
·
Jul 24

West Pharmaceutical lifts guidance on HVP-driven surge

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and Thermo Fisher (TMO)

TIPRANKS
·
Jul 24

GLP-1 concerns around West Pharmaceutical feel overdone, says Evercore ISI

TIPRANKS
·
Jul 24

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

Benzinga Earnings
·
Jul 23

West Pharmaceutical Services Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

West Pharma Rises After Raising Annual Forecasts

Reuters
·
Jul 23

Stock Track | West Pharmaceutical Soars 6.02% in Pre-market on Strong Q2 Earnings Beat and Raised 2026 Guidance

Stock Track
·
Jul 23

West Pharmaceutical Raises Annual Profit Forecast on Strong Demand for Injectable Drug Components

Reuters
·
Jul 23

West Pharma Q2 FY26 EPS Rises 18.1% to $2.15; Net Sales Increase 13.8% to $872.3 Million

Reuters
·
Jul 23

GUIDANCE: (WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.85 - $9.05, vs. FactSet Est of $8.62

MT Newswires Live
·
Jul 23

West Pharmaceutical Q2 Adjusted EPS USD 2.37 Vs. IBES Estimate USD 2.08

Reuters
·
Jul 23

West Pharmaceutical Services - Guides Q3 2026 Adj-diluted EPS to $2.14-$2.24

THOMSON REUTERS
·
Jul 23

West Pharmaceutical Services - Guides Q3 2026 Net Sales to $820-$835 Mln

THOMSON REUTERS
·
Jul 23